Quantgene
PrivateLast Round
Crowdfunding
Nov 1, 2026
Est. Valuation
$60M
Total Funding Raised
$12.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Quantgene operates in Healthcare & Life Sciences and is based in Hillsboro, Oregon. Its latest recorded funding round was a VC Round in February 2021.
Quantgene is a biotechnology company that develops a deep genomics platform designed to prevent and detect diseases at an early stage.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quantgene Comparables
Compare Quantgene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Freenome | 78% | |
| Lucence | 77% | |
| Genomic Life | 77% |
For institutional investors. Book with your work email.
Quantgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Nov 1, 2026 | ||||
| VC Round | Feb 17, 2021 | ||||
| Convertible Debt | Apr 1, 2020 |
For institutional investors. Book with your work email.
Quantgene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Crowdfunding |
| Moore Capital Management | Crowdfunding |
| Lyrical Partners | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
Raised $60M post-money from Lyrical Partners and Moore Capital Management.
- Feb 17, 2021
$6M round led by Vanta Diagnostics.
For institutional investors. Book with your work email.
Quantgene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quantgene's valuation, stock price, and market status.
Is Quantgene a public or private company?
Quantgene is a private company.
What is the current stock price of Quantgene?
Quantgene is a private company, so its shares have no public market price. Caplight tracks Quantgene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quantgene worth (valuation)?
Quantgene's valuation is estimated at $60.0M based on funding round data.
Can I buy Quantgene stock?
Quantgene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quantgene's last funding round?
Quantgene's most recent funding round was Crowdfunding on November 1, 2026.
Who are the main investors in Quantgene?
Key investors in Quantgene include StartUp Health, Moore Capital Management, Lyrical Partners.
Will Quantgene IPO soon?
No public IPO plans have been announced for Quantgene.
How can I track Quantgene secondary market activity?
Caplight tracks bids, offers, and trades in Quantgene's shares on secondary markets.